<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02592616</url>
  </required_header>
  <id_info>
    <org_study_id>H-15008542</org_study_id>
    <nct_id>NCT02592616</nct_id>
  </id_info>
  <brief_title>Interval-training and Appetite Regulation in Patients With Type 2 Diabetes</brief_title>
  <official_title>Interval-training and Appetite Regulation in Patients With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Four months of interval walking (IW) training results in substantial weight loss in
      opposition to energy-expenditure matched continuous walking (CW) training. The reason for
      this is unclear.

      This study will assess if IW leads to greater exercise-induced suppression of appetite and ad
      libitum food intake compared to CW and no exercise.

      Subjects with type 2 diabetes will be included in a crossover, counter-balanced, controlled
      study, where each subject will undergo three trials. Trials will be identical except the
      following interventions:

        1. One hour of rest (CON)

        2. One hour of interval walking (repeated cycles of 3 min of fast and 3 min of slow
           walking; IW)

        3. One hour of continuous walking (CW) matched to IW with regards to energy-expenditure.

      After the interventions subjects will undergo a liquid mixed meal tolerance test (450 kCal),
      with regular measurements of appetite-related hormones (insulin, ghrelin, Leptin,
      Cholecystokinin, PYY). Three hours into the mixed meal tolerance test, a standardised
      ad-libitum meal test will be served and intake will recorded. Free-living energy intake via
      food records will be assessed during the following 32 hours.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ad-libitum meal energy intake</measure>
    <time_frame>Initiated 3 hours after the intervention</time_frame>
    <description>Subjects will receive a standardized ad-libitum meal and energy intake will be assessed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Free-living energy intake</measure>
    <time_frame>For 32 hours following the ad-libitum meal.</time_frame>
    <description>Subjects will complete diet records for 32 hours following the ad-libitum meal and energy intake will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appetite-related hormones</measure>
    <time_frame>Regularly during the 3 hours following the intervention</time_frame>
    <description>Appetite-related hormones (insulin, ghrelin, leptin, cholecyctokinin, PYY) will be analysed in blood samples collected regularly during the liquid mixed-meal tolerance test following the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satiety</measure>
    <time_frame>Regular assessments for 36 hours following the intervention</time_frame>
    <description>Satiety questionaires will be completed at regular intervals after the intervention</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>CON</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Control (CON).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CW</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous Walking (CW).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IW</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interval Walking (IW).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CON</intervention_name>
    <description>No exercise intervention.</description>
    <arm_group_label>CON</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CW</intervention_name>
    <description>One hour of continuous walking on a treadmill.</description>
    <arm_group_label>CW</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>IW</intervention_name>
    <description>One hour of interval (repeated cycles of 3 minutes of fast and 3 minutes of slow) walking on treadmill.</description>
    <arm_group_label>IW</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 Diabetes Mellitus

          -  BMI &gt; 25

        Exclusion Criteria:

          -  Pregnancy

          -  Smoking

          -  Contraindication to increased levels of physical activity

          -  Eating disorder

          -  Insulin dependence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Center for Physical Activity Research (CFAS)</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2015</study_first_submitted>
  <study_first_submitted_qc>October 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2015</study_first_posted>
  <last_update_submitted>June 21, 2016</last_update_submitted>
  <last_update_submitted_qc>June 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Anders Rasmussen Rinnov</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Exercise</keyword>
  <keyword>Appetite</keyword>
  <keyword>Energy intake</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

